ETS2 is a prostate basal cell marker and is highly expressed in prostate cancers aberrantly expressing p63-Reference-Cited by-同舟云学术

ETS2 is a prostate basal cell marker and is highly expressed in prostate cancers aberrantly expressing p63

Published:2018-05-15 Issue:12 Volume:78 Page:896-904
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Torres Alba¹,Alshalalfa Mohammed²,Davicioni Elai²,Gupta Anuj³,Yegnasubramanian Srinivasan³,Wheelan Sarah J.³⁴,Epstein Jonathan I.¹³⁵^ORCID,De Marzo Angelo M.¹³⁵,Lotan Tamara L.¹³^ORCID

Affiliation:

1. Department of Pathology; Johns Hopkins School of Medicine; Baltimore Maryland

2. GenomeDx Biosciences; Vancouver British Columbia

3. Department of Oncology; Johns Hopkins School of Medicine; Baltimore Maryland

4. Department of Biostatistics; Johns Hopkins Bloomberg School of Public Health; Baltimore Maryland

5. Department of Urology; Johns Hopkins School of Medicine; Baltimore Maryland

Funder

National Cancer Institute

National Institutes of Health

the US Department of Defense Prostate Cancer Research Program (PCRP)

the Prostate Cancer Biorepository Network (PCBN)

GenomeDx

Publisher

Wiley

Subject

Urology,Oncology

Reference27 articles.

1. Aberrant diffuse expression of p63 in adenocarcinoma of the prostate on needle biopsy and radical prostatectomy: report of 21 cases;Osunkoya;Am J Surg Pathol,2008

2. Aberrant expression of p63 in adenocarcinoma of the prostate: a radical prostatectomy study;Giannico;Am J Surg Pathol,2013

3. Prostate adenocarcinomas aberrantly expressing p63 are molecularly distinct from usual-type prostatic adenocarcinomas;Tan;Mod Pathol,2015

4. DeltaNp63 (p40) expression in prostatic adenocarcinoma with diffuse p63 positivity;Uchida;Hum Pathol,2015

5. A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomy;Ross;Prostate Cancer Prostatic Dis,2014

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aggressive prostatic adenocarcinoma with urothelial-like morphology, with frequent CK7/CK20/HMWK expression and occasional diffuse neuroendocrine features: A clinicopathologic study of 12 cases;Pathology - Research and Practice;2024-02

2. Chromosome 21;Cancer Genes: Volume 2;2023-08-16

3. Basal epithelial cells in prostate development, tumorigenesis, and cancer progression;Cell Cycle;2023-04-26

4. Prostate Gland;Handbook of Practical Immunohistochemistry;2022

5. GSTP1 positive prostatic adenocarcinomas are more common in Black than White men in the United States;PLOS ONE;2021-06-30